Results 141 to 150 of about 16,846 (200)

TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes [PDF]

, 2016
et al,, Fronick, C. C., Fulton, R. S., Ley, T. J., Miller, C. A., O\u27Laughlin, M., Petti, A. A., Wartman, L. D., Wilson, R. K.   +8 more
core   +2 more sources

Clonal determinants of organotropism and survival in metastatic uveal melanoma. [PDF]

NPJ Precis Oncol
Jones BSCL, Hammes E, Demkowicz PC, Matesva M, Pointdujour-Lim R, Sinard JH, Bacchiocchi A, Halaban R, Bosenberg M, Sznol M, Kluger HM, Bakhoum MF.   +11 more
europepmc   +1 more source

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat. [PDF]

Leukemia
Santini V, Zeidan AM, Van Eygen K, Fenaux P, Germing U, Madanat YF, Raza A, Savona MR, Sekeres MA, Thépot S, Raddi MG, Boyer T, Sun L, Wan Y, Berry T, Xia Q, Huang F, Dougherty S, Navada S, Feller F, Komrokji RS, Platzbecker U.   +21 more
europepmc   +1 more source

RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma. [PDF]

Biomark Res
Utrilla-Maestre A, Matia-González AM, Peinado P, Becerra-Rodriguez MA, Benitez-Cantos MS, Cuadros M, Medina PP.   +6 more
europepmc   +1 more source

Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. [PDF]

Ann Med
Zhang L, Ying S, Fang F, Li Q, An F, Li J, Sun J, Zheng W, Zhai Z, Zhu Y.   +9 more
europepmc   +1 more source

Correction: Dhillon et al. Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review. <i>Cancers</i> 2025, <i>17</i>, 3610. [PDF]

Cancers (Basel)
Dhillon V, Maciejewski J, Balasubramanian SK.   +2 more
europepmc   +1 more source

Targeting CDK11 in Rhabdoid Tumor of the Kidney. [PDF]

Cancers (Basel)
Murakami Y, Lam K, Fukui S, Helmke E, Iczkowski KA, Li Y, Satake N.   +6 more
europepmc   +1 more source

Insights into the structure and evolution of the human SAGA complex by affinity-ligand purification. [PDF]

Sci Adv
Damilot M, Schoeps T, Tora L, Schultz P, Lebeau L, Papai G, Ben-Shem A.   +6 more
europepmc   +1 more source

SF3B1 mutation arises at the multipotent HSC level [PDF]

Blood, 2017
openaire   +2 more sources

Clonal haematopoiesis and risk of incident rheumatoid arthritis: results from the UK biobank. [PDF]

Clin Exp Rheumatol
Cui J, Yu Z, Oakes EG, Truong B, Uddin M, Bick A, Niroula A, Solomon DH, Natarajan P, Costenbader KH.   +9 more
europepmc   +1 more source